TSLA
Tesla
-- 421.060 PLTR
Palantir
-- 80.550 NVDA
NVIDIA
-- 134.700 OXY
Occidental Petroleum
-- 47.130 AMD
Advanced Micro Devices
-- 119.210 
BxB Main Portfolio
Here’s a financial overview of BxB Main Follow: Paperfolio
1. $NVIDIA (NVDA.US)$ Revenue: For Q3 FY2025, Nvidia reported a record revenue of $35.1 billion, a 94% increase year-over-year. Data Center revenue contributed $30.8 billion, driven by AI adoption.
• Profit: Net income for FY2024 was $29.76 billion, up from $4.37 billion in FY2023, showcasing rapid growth in AI and gaming sectors. Nvidia’s financial statements gov/Archives/ed...
• Profit: Net income for FY2024 was $29.76 billion, up from $4.37 billion in FY2023, showcasing rapid growth in AI and gaming sectors. Nvidia’s financial statements gov/Archives/ed...
2. $IonQ Inc (IONQ.US)$ Focused on quantum computing, IonQ has seen steady growth in its bookings, with a reported $28.2 million in Q3 2024 bookings, exceeding its annual target.
3. $C3.ai (AI.US)$ focuses on enterprise AI software. In FY2023, the company achieved revenue of $266.8 million, with a strategic shift toward consumption-based pricing impacting growth projections.
4. $Quantum Computing (QUBT.US)$ reported moderate revenues in its early-stage development, focusing on partnerships to advance quantum solutions. Q3 2024 saw a slight increase in revenues.
5. $D-Wave Quantum (QBTS.US)$ another quantum computing pioneer, reported revenues around $1.6 million in Q3 2024, reflecting its focus on quantum annealing technology for enterprise adoption.
6. $Riot Platforms (RIOT.US)$ focused on cryptocurrency mining, reported $76.7 million in Q3 2024 revenue, driven by Bitcoin mining operations. The volatile crypto market continues to impact their financial outcomes.
7. $CleanSpark (CLSK.US)$ reported $24.2 million in Q3 FY2024, capitalizing on sustainable energy solutions for Bitcoin mining.
8. $Clearwater Analytics (CWAN.US)$ focuses on SaaS for investment management. Q3 2024 revenue reached $96 million, marking an increase due to client acquisitions in insurance and asset management.
9. $Palantir (PLTR.US)$ reported $553 million in Q3 2024 revenue, with significant growth in AI-driven analytics for government and commercial sectors.
10. $Verint Systems (VRNT.US)$ specializing in customer engagement solutions, Verint reported Q2 FY2024 revenue of $224 million. The company is transitioning to a cloud-based SaaS model.
11. $Fulgent Genetics (FLGT.US)$, focused on genetic testing, reported $67 million in Q3 2024 revenue. It is expanding into oncology and precision medicine.
3. $C3.ai (AI.US)$ focuses on enterprise AI software. In FY2023, the company achieved revenue of $266.8 million, with a strategic shift toward consumption-based pricing impacting growth projections.
4. $Quantum Computing (QUBT.US)$ reported moderate revenues in its early-stage development, focusing on partnerships to advance quantum solutions. Q3 2024 saw a slight increase in revenues.
5. $D-Wave Quantum (QBTS.US)$ another quantum computing pioneer, reported revenues around $1.6 million in Q3 2024, reflecting its focus on quantum annealing technology for enterprise adoption.
6. $Riot Platforms (RIOT.US)$ focused on cryptocurrency mining, reported $76.7 million in Q3 2024 revenue, driven by Bitcoin mining operations. The volatile crypto market continues to impact their financial outcomes.
7. $CleanSpark (CLSK.US)$ reported $24.2 million in Q3 FY2024, capitalizing on sustainable energy solutions for Bitcoin mining.
8. $Clearwater Analytics (CWAN.US)$ focuses on SaaS for investment management. Q3 2024 revenue reached $96 million, marking an increase due to client acquisitions in insurance and asset management.
9. $Palantir (PLTR.US)$ reported $553 million in Q3 2024 revenue, with significant growth in AI-driven analytics for government and commercial sectors.
10. $Verint Systems (VRNT.US)$ specializing in customer engagement solutions, Verint reported Q2 FY2024 revenue of $224 million. The company is transitioning to a cloud-based SaaS model.
11. $Fulgent Genetics (FLGT.US)$, focused on genetic testing, reported $67 million in Q3 2024 revenue. It is expanding into oncology and precision medicine.
Read More: Trending Posts over 1,000,000 views
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Coach Donnie : Let’s GOOO